Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
206873-63-4
|
| gptkbp:developedBy |
gptkb:Aventis
|
| gptkbp:function |
P-glycoprotein inhibitor
|
| gptkbp:hasMolecularFormula |
C38H38N4O6
|
| https://www.w3.org/2000/01/rdf-schema#label |
tariquidar
|
| gptkbp:IUPACName |
N-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide
|
| gptkbp:mechanismOfAction |
inhibits multidrug resistance protein P-gp
|
| gptkbp:molecularWeight |
646.73 g/mol
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL1201737
148200 |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational drug
|
| gptkbp:synonym |
XR9576
|
| gptkbp:UNII |
6O6F6J9E5V
|
| gptkbp:used_in |
cancer research
|
| gptkbp:bfsParent |
gptkb:MDR1
gptkb:Multidrug_resistance_protein_1 |
| gptkbp:bfsLayer |
7
|